Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Kardiologia Polska
|
January 1, 1992
[Thrombolytic therapy of myocardial infarction. Prognostic value of early reduction of elevation of ST segment]
Z Sadowski, E Pietrzyk, K Baraniewski, et al.
Kardiologia Polska
|
May 1, 1992
[Does the appearance of pro-arrhythmic response to anti-arrhythmic drugs have prognostic significance?]
M Trusz-Gluza, L Giec, A Dabrowski, et al.
Journal of Internal Medicine
|
May 1, 1995
Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease
J Słowińska-Srzednicka, B Malczewska, M Srzednicki, et al.
Journal of Endocrinological Investigation
|
July 1, 1991
The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome
J Slowińska-Srzednicka, S Zgliczyński, M Wierzbicki, et al.
American Heart Journal
|
April 30, 1999
Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators
J H Alexander, C B Granger, Z Sadowski, et al.
Journal of the American College of Cardiology
|
September 1, 1995
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
D R Holmes, E R Bates, N S Kleiman, et al.
Journal of the American College of Cardiology
|
November 1, 1995
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries
G I Barbash, J Reiner, H D White, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
September 25, 1998
Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study
Z Sadowski, H Szwed, A Kuch-Wocial, et al.
Cardiovascular Drugs and Therapy
|
August 10, 1999
The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1
H Szwed, Z Sadowski, R Pachocki, et al.
Circulation
|
September 15, 1996
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators
R M Califf, H D White, F Van de Werf, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Kardiologia Polska
|
January 1, 1992
[Thrombolytic therapy of myocardial infarction. Prognostic value of early reduction of elevation of ST segment]
Z Sadowski, E Pietrzyk, K Baraniewski, et al.
Kardiologia Polska
|
May 1, 1992
[Does the appearance of pro-arrhythmic response to anti-arrhythmic drugs have prognostic significance?]
M Trusz-Gluza, L Giec, A Dabrowski, et al.
Journal of Internal Medicine
|
May 1, 1995
Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease
J Słowińska-Srzednicka, B Malczewska, M Srzednicki, et al.
Journal of Endocrinological Investigation
|
July 1, 1991
The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome
J Slowińska-Srzednicka, S Zgliczyński, M Wierzbicki, et al.
American Heart Journal
|
April 30, 1999
Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators
J H Alexander, C B Granger, Z Sadowski, et al.
Journal of the American College of Cardiology
|
September 1, 1995
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
D R Holmes, E R Bates, N S Kleiman, et al.
Journal of the American College of Cardiology
|
November 1, 1995
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries
G I Barbash, J Reiner, H D White, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
September 25, 1998
Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study
Z Sadowski, H Szwed, A Kuch-Wocial, et al.
Cardiovascular Drugs and Therapy
|
August 10, 1999
The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1
H Szwed, Z Sadowski, R Pachocki, et al.
Circulation
|
September 15, 1996
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators
R M Califf, H D White, F Van de Werf, et al.
Page
of 7